Request Trial
22 December 2024AmericasBethan Hopewell, Partner, Powell Gilbert/Joel Coles, Partner, Powell Gilbert/Siddharth Kusumakar, Partner, Powell Gilbert

WATCH: The European IP landscape

Bethan Hopewell, Joel Coles, and Siddharth Kusumakar, partners at Powell Gilbert, discuss the significant developments in the European patent landscape in 2024, not only at the UPC but also at the EPO.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Americas
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
10 July 2026   Harbour’s trial counsel shares the strategy behind the company’s $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science.
Americas
Exelixis opens two-front patent dispute over Cabometyx copies
9 July 2026   Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the US market until key patents expire.
Americas
LSD trade secrets suit over clinical trail info thrown out by judge
2 July 2026   A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over allegations of trade secret misuse during a bidding process.


Editor's picks

Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
Pharma
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026

Editor's picks

Pharma
Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer
15 July 2026
Americas
Pfizer’s US Paxlovid patent fight turns on a single error
25 June 2026
Biotech
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
25 June 2026
Biotech
Insilico lands potential $2.5bn AI biotech partnership
22 June 2026
Pharma
US life sciences damages averaged $33.5m between 2019-2025
18 June 2026
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

More features

Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
Exelixis opens two-front patent dispute over Cabometyx copies
LSD trade secrets suit over clinical trail info thrown out by judge
Will Mounjaro and Zepbound get their first US generic rival?
Pfizer’s US Paxlovid patent fight turns on a single error
Court upholds $83m sequencing verdict and sets royalty rate
Exclusive: ‘Cultural differences are an asset’ at the UPC
Amgen and subsidiary dealt $20m blow over rodent antibody tech